The α-synuclein PFF model has become a widely used animal model of Parkinson’s disease, involving the central or peripheral injection of recombinant α-synuclein protein fibrils19 to trigger widespread α-synuclein phosphorylation and aggregation throughout the brain. This evidence concerns the gene SNCA and Parkinson disease.